Sorry, your browser does not support JavaScript!
Investor Relations
Contact Us
KiteKonnect®
About Us
Our Mission
Our Story
Therapeutic Areas
Leadership
Kite Locations
Grants
Science & Medicine
Our Technology
Our Therapies
Pipeline
Trials & Expanded Access
External Research Program (ERP)
Newsroom
Newsroom
Press Releases
Media Kit
Careers
Careers at Kite
Culture & Benefits
Internships
Utility
Contact Us
KiteKonnect®
Investor Relations
Toggle Inner Dropdown
BACK TO MAIN MENU
Google.com
Newsroom
Recent Press Releases
June 12, 2020
Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe
May 29, 2020
Yescarta® (Axicabtagene Ciloleucel) Demonstrates High Rates of Response in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
Explore More
Media Inquiries
Gilead Newsroom
Twitter Feed
